The top 5 vaccines by 2020

June 26, 2014

Pfizer's ($PFE) Prevnar 13 currently dominates the list of the world's best-selling vaccines--and that won't be changing anytime soon, according to a new report from EvaluatePharma. In fact, it's expected to widen its lead, with sales growing more than 61% over the next 5+ years; by 2020, it will be generating nearly $4 billion more than runner up Pentacel from Sanofi ($SNY), EP predicts.

Check out the projections for the top 5 best-selling vaccines by 2020, and see how they stack up to those on the 2013 list.

 

Sign up for FierceVaccines's free email newsletter to see how the 2020 forecast stacks up.

 

 


If you're having difficulty with this form, please email audience@fiercemarkets.com for assistance.